Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,177 | 674 | 58.1% |
| Consulting Fee | $8,231 | 9 | 29.6% |
| Unspecified | $2,186 | 1 | 7.9% |
| Education | $624.57 | 14 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $470.00 | 2 | 1.7% |
| Travel and Lodging | $135.33 | 1 | 0.5% |
| Entertainment | $20.61 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $7,269 | 53 | $0 (2024) |
| Astellas Pharma US Inc | $2,481 | 104 | $0 (2024) |
| Spectrum Pharmaceuticals Inc. | $2,186 | 1 | $0 (2018) |
| NeoTract Inc. | $1,185 | 17 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,092 | 29 | $0 (2024) |
| Lutonix, Inc. | $1,000 | 1 | $0 (2018) |
| Dendreon Pharmaceuticals LLC | $985.98 | 36 | $0 (2024) |
| Axonics, Inc. | $916.75 | 15 | $0 (2024) |
| ABBVIE INC. | $738.20 | 38 | $0 (2024) |
| UROVANT SCIENCES INC | $669.84 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,334 | 110 | Astellas Pharma US Inc ($596.68) |
| 2023 | $8,564 | 81 | Janssen Biotech, Inc. ($6,407) |
| 2022 | $2,182 | 88 | Janssen Biotech, Inc. ($318.45) |
| 2021 | $2,704 | 93 | UROVANT SCIENCES INC ($454.66) |
| 2020 | $1,652 | 44 | Cepheid ($492.00) |
| 2019 | $1,943 | 92 | Astellas Pharma US Inc ($252.51) |
| 2018 | $5,622 | 101 | Spectrum Pharmaceuticals Inc. ($2,186) |
| 2017 | $1,842 | 93 | NeoTract Inc. ($264.02) |
All Payment Transactions
702 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/03/2024 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $127.55 | General |
| Category: Urology | ||||||
| 12/03/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $113.18 | General |
| Category: Urology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: HORMONE THERAPY | ||||||
| 11/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $36.53 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: UROLOGY | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: HORMONE THERAPY | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $146.59 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: HORMONE THERAPY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SPI-QAP-306 | Spectrum Pharmaceuticals Inc. | $2,186 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,815 | 8,890 | $975,474 | $322,194 |
| 2022 | 32 | 4,117 | 8,728 | $1.1M | $360,762 |
| 2021 | 30 | 3,803 | 5,017 | $961,240 | $324,483 |
| 2020 | 29 | 3,030 | 6,011 | $715,385 | $262,011 |
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 542 | 616 | $181,170 | $58,430 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 425 | 712 | $145,919 | $49,955 | 34.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 122 | 605 | $51,425 | $30,311 | 58.9% |
| J3490 | Unclassified drugs | Office | 2023 | 22 | 45 | $51,600 | $29,818 | 57.8% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 577 | 686 | $70,001 | $26,264 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $40,812 | $13,637 | 33.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 19 | 105 | $84,000 | $13,341 | 15.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 181 | $21,177 | $11,950 | 56.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 76 | 80 | $37,782 | $10,066 | 26.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 110 | 150 | $90,000 | $9,688 | 10.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 1,500 | $12,600 | $7,468 | 59.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 48 | $15,168 | $6,985 | 46.1% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $14,820 | $6,252 | 42.2% |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | Facility | 2023 | 12 | 15 | $13,920 | $4,645 | 33.4% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 15 | 1,850 | $10,450 | $4,190 | 40.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 12 | 12 | $9,703 | $3,789 | 39.1% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 12 | $9,420 | $3,546 | 37.6% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 18 | 47 | $10,024 | $3,542 | 35.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 770 | 1,104 | $8,832 | $3,418 | 38.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 311 | 401 | $4,715 | $3,352 | 71.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 57 | 65 | $4,903 | $3,023 | 61.6% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 22 | 36 | $6,420 | $2,838 | 44.2% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 21 | 21 | $9,555 | $2,280 | 23.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 12 | 12 | $4,392 | $2,005 | 45.7% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 12 | 14 | $7,700 | $1,980 | 25.7% |
About Dr. Guy Bernstein, MD
Dr. Guy Bernstein, MD is a Specialist healthcare provider based in Bryn Mawr, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639178551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guy Bernstein, MD has received a total of $27,845 in payments from pharmaceutical and medical device companies, with $3,334 received in 2024. These payments were reported across 702 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($16,177).
As a Medicare-enrolled provider, Bernstein has provided services to 14,765 Medicare beneficiaries, totaling 28,646 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Urology
- Location Bryn Mawr, PA
- Active Since 07/21/2005
- Last Updated 05/31/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1639178551
Products in Payments
- ERLEADA (Drug) $7,358
- PROVENGE (Drug) $1,174
- XTANDI (Drug) $1,124
- Xtandi (Drug) $870.91
- BOTOX (Biological) $656.62
- GEMTESA (Drug) $655.43
- Axonics (Device) $609.76
- INTERSTIM (Device) $607.64
- UroLift (Device) $570.89
- Nubeqa (Drug) $554.72
- Xofigo (Drug) $537.65
- MYRBETRIQ (Drug) $514.79
- GENEXPERT (Device) $492.00
- XIAFLEX (Biological) $448.24
- KEYTRUDA (Biological) $403.71
- FIRMAGON (Drug) $381.57
- Noctiva (Drug) $375.97
- Urolift (Device) $350.00
- UROLIFT (Device) $347.42
- Myrbetriq (Drug) $306.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bryn Mawr
Stuart Lessin, M.d, M.D
Specialist — Payments: $182,736
Dr. Jane Porcelan, Md, MD
Specialist — Payments: $8,633
Dr. James Duckett, Md, MD
Specialist — Payments: $2,127
Steven Cohen, M.d, M.D
Specialist — Payments: $891.14
Dr. Eric Rosenberg, Md, MD
Specialist — Payments: $260.52
Dr. Michael Lilian, Md, MD
Specialist — Payments: $236.05